Literature DB >> 10792212

Is morphoea caused by Borrelia burgdorferi? A review.

B Weide1, T Walz, C Garbe.   

Abstract

The aetiology of morphoea and lichen sclerosus et atrophicus is still unknown. Since the detection of Borrelia burgdorferi (B. burgdorferi) as the causative agent of Lyme disease, there has been debate about a possible association between B. burgdorferi and morphoea. Initial serological and cultural studies showed controversial results. The introduction of polymerase chain reaction (PCR) initially suggested an association between B. burgdorferi and morphoea. We reviewed the literature on B. burgdorferi (specific serology, immunohistology, culture, lymphocyte stimulation and DNA detection by PCR) since 1983, using Medline and Current Contents. Histological and immunohistological detection of B. burgdorferi was reported in 0-40% (20 of 82) of the cases with morphoea and in 46-50% (17 of 36) of the cases with lichen sclerosus et atrophicus. Cultivation of spirochetes from lesional skin succeeded in five patients (five of 68) with morphoea, but failed in patients with lichen sclerosus et atrophicus. In Europe and Asia, serological detection of antibodies against B. burgdorferi was described in 0-60% (138 of 609) of patients with morphoea and in 19% (six of 32) in the U.S.A. For lichen sclerosus et atrophicus 0-25% of the published cases (three of 23) in Europe and Asia were seropositive. DNA from B. burgdorferi was detected by PCR in 0-100% (17 of 82) of the tissues of patients with morphoea in Europe and Asia, but not a single case among 98 patients was reported to be positive from the U. S.A. In Europe and Asia, borrelial DNA was detected in 0-100% (nine of 28) of the cases with lichen sclerosus et atrophicus, whereas in the U.S.A. none of 48 patients was positive. There are two possible explanations for these contradictory findings: the most likely is that B. burgdorferi is not a causative agent for morphoea. Another possible explanation could be that a subset of morphoea is caused by a special subspecies of B. burgdorferi that is present in Europe and Asia but does not occur in the U.S.A.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792212     DOI: 10.1046/j.1365-2133.2000.03407.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  Lichen Sclerosus and Other Conditions Mimicking Vulvovaginal Candidiasis.

Authors:  Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

2.  Sensitive detection of Borrelia burgdorferi sensu lato DNA and differentiation of Borrelia species by LightCycler PCR.

Authors:  S Mommert; R Gutzmer; A Kapp; T Werfel
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 3.  Morphoea and Borrelia burgdorferi: results from the Scottish Highlands in the context of the world literature.

Authors:  J R Goodlad; M M Davidson; P Gordon; R Billington; D O Ho-Yen
Journal:  Mol Pathol       Date:  2002-12

Review 4.  Scleroderma-like cutaneous syndromes.

Authors:  Yasuji Mori; Veli-Matti Kahari; John Varga
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

Review 5.  Development of minimum standards of care for juvenile localized scleroderma.

Authors:  Tamás Constantin; Ivan Foeldvari; Clare E Pain; Annamária Pálinkás; Peter Höger; Monika Moll; Dana Nemkova; Lisa Weibel; Melinda Laczkovszki; Philip Clements; Kathryn S Torok
Journal:  Eur J Pediatr       Date:  2018-05-04       Impact factor: 3.183

6.  A case of localized scleroderma in a sculptor and his wife.

Authors:  Richard Bakst; Carrie Kovarik; Victoria P Werth
Journal:  J Clin Rheumatol       Date:  2009-12       Impact factor: 3.517

7.  [The variable spectrum of cutaneous Lyme borreliosis. Diagnosis and therapy].

Authors:  H Hofmann
Journal:  Hautarzt       Date:  2012-05       Impact factor: 0.751

8.  The intersection of microbiome and host at the skin interface: genomic- and metagenomic-based insights.

Authors:  Elizabeth A Grice
Journal:  Genome Res       Date:  2015-10       Impact factor: 9.043

9.  Infections are not increased in scleroderma compared to non-inflammatory musculoskeletal disorders prior to disease onset.

Authors:  Janet E Pope; Jodi L Goodwin; Janine M Ouimet; Adriana Krizova; Matthew Laskin
Journal:  Open Rheumatol J       Date:  2007-11-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.